Literature DB >> 26425443

Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches.

Subho Chakrabarti1.   

Abstract

Telepsychiatry, i.e., the use of information and communication technologies to provide psychiatric services from a distance, has been around for more than half a century now. Research over this period has shown that videoconferencing-based telepsychiatry is an enabling and empowering form of service delivery, which promotes equality of access, and high levels of satisfaction among patients. The range of services offered by videoconferencing-based telepsychiatry, potential users and points of delivery of such services are theoretically limitless. Telepsychiatry has both clinical utility and non-clinical uses such as administrative, learning and research applications. A large body of accumulated evidence indicates that videoconferencing-based telepsychiatric assessments are reliable, and clinical outcomes of telepsychiatric interventions are comparable to conventional treatment among diverse patient populations, ages and diagnostic groups, and on a wide range of measures. However, on many aspects of effectiveness, the evidence base is still relatively limited and often compromised by methodological problems. The lack of cost-effectiveness data in particular, is a major hindrance, raising doubts about the continued viability of telepsychiatric services. Added to this are the vagaries of technology, negative views among clinicians, poor uptake by providers, and several legal, ethical and administrative barriers. These hamper the widespread implementation of telepsychiatry and its integration with routine care. Though further advances in technology and research are expected to solve many of these problems, the way forward would be to promote telepsychiatry as an adjunct to conventional care, and to develop hybrid models, which incorporate both traditional and telepsychiatric forms of mental health-care.

Entities:  

Keywords:  Assessment; Effectiveness; Efficacy; Management; Outcome; Reliability; Tele-mental-health; Telepsychiatry; Videoconferencing

Year:  2015        PMID: 26425443      PMCID: PMC4582305          DOI: 10.5498/wjp.v5.i3.286

Source DB:  PubMed          Journal:  World J Psychiatry        ISSN: 2220-3206


  154 in total

1.  Scoring written material from the Mini-Mental State Examination: a comparison of face-to-face, fax and video-linked scoring.

Authors:  C Ball; J Tyrrell; C Long
Journal:  J Telemed Telecare       Date:  1999       Impact factor: 6.184

Review 2.  Videoconferencing psychotherapy: a systematic review.

Authors:  Autumn Backhaus; Zia Agha; Melissa L Maglione; Andrea Repp; Bridgett Ross; Danielle Zuest; Natalie M Rice-Thorp; James Lohr; Steven R Thorp
Journal:  Psychol Serv       Date:  2012-05

Review 3.  Teleconsultation in psychology: the use of videolinks for interviewing and assessing elderly patients.

Authors:  J Tyrrell; P Couturier; C Montani; A Franco
Journal:  Age Ageing       Date:  2001-05       Impact factor: 10.668

4.  Telepsychiatry in Africa -- a way forward?

Authors:  M Mars
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2012-07

Review 5.  Limitations of patient satisfaction studies in telehealthcare: a systematic review of the literature.

Authors:  T L Williams; C R May; A Esmail
Journal:  Telemed J E Health       Date:  2001       Impact factor: 3.536

6.  "Telepsychometry": a remote psychometry consultation in clinical gerontology: preliminary study.

Authors:  C Montani; N Billaud; P Couturier; I Fluchaire; R Lemaire; C Malterre; N Lauvernay; J F Piquard; M Frossard; A Franco
Journal:  Telemed J       Date:  1996

7.  The feasibility of videoconferencing for neuropsychological assessments of rural youth experiencing early psychosis.

Authors:  Helen J Stain; Kristy Payne; Renate Thienel; Pat Michie; Vaughan Carr; Brian Kelly
Journal:  J Telemed Telecare       Date:  2011-08-15       Impact factor: 6.184

8.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

Review 9.  Telepsychology outcome research with children and adolescents: a review of the literature.

Authors:  Norah C Slone; Robert J Reese; Michael J McClellan
Journal:  Psychol Serv       Date:  2012-08

Review 10.  Emergency telepsychiatry.

Authors:  Peter Yellowlees; Michelle M Burke; Shayna L Marks; Donald M Hilty; Jay H Shore
Journal:  J Telemed Telecare       Date:  2008       Impact factor: 6.184

View more
  76 in total

Review 1.  Remote Telepsychiatry Workforce: a Solution to Psychiatry's Workforce Issues.

Authors:  Jordan S Gardner; Brittany E Plaven; Peter Yellowlees; Jay H Shore
Journal:  Curr Psychiatry Rep       Date:  2020-01-27       Impact factor: 5.285

2.  Applying lessons from task sharing in global mental health to the opioid crisis.

Authors:  Jessica F Magidson; Helen E Jack; Kristen S Regenauer; Bronwyn Myers
Journal:  J Consult Clin Psychol       Date:  2019-10

Review 3.  Use of Telepsychiatry in Emergency and Crisis Intervention: Current Evidence.

Authors:  Isabelle Reinhardt; Euphrosyne Gouzoulis-Mayfrank; Jürgen Zielasek
Journal:  Curr Psychiatry Rep       Date:  2019-07-01       Impact factor: 5.285

4.  Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption.

Authors:  Lewei Allison Lin; Anne C Fernandez; Erin E Bonar
Journal:  JAMA Psychiatry       Date:  2020-12-01       Impact factor: 21.596

Review 5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Authors:  Sagar V Parikh; Lena C Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

6.  Telemental Health and US Rural-Urban Differences in Specialty Mental Health Use, 2010-2017.

Authors:  Sadiq Y Patel; Haiden A Huskamp; Alisa B Busch; Ateev Mehrotra
Journal:  Am J Public Health       Date:  2020-07-16       Impact factor: 9.308

7.  Telepsychiatry: an Innovative Approach to Addressing the Opioid Crisis.

Authors:  Hossam Mahmoud; Emily Vogt
Journal:  J Behav Health Serv Res       Date:  2019-10       Impact factor: 1.505

8.  Challenges and Opportunities to Meet the Mental Health Needs of Underserved and Disenfranchised Populations in the United States.

Authors:  Francesca Mongelli; Penelope Georgakopoulos; Michele T Pato
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-01-24

9.  Characterizing Family Physicians Who Refer to Telepsychiatry in Ontario.

Authors:  Eva Serhal; Tomisin Iwajomo; Claire de Oliveira; Allison Crawford; Paul Kurdyak
Journal:  Can J Psychiatry       Date:  2020-09-10       Impact factor: 4.356

10.  Impacts of COVID-19 on Mental Health Safety Net Services for Youths: A National Survey of Agency Officials.

Authors:  Jonathan Purtle; Katherine L Nelson; Sarah McCue Horwitz; Lawrence A Palinkas; Mary M McKay; Kimberly E Hoagwood
Journal:  Psychiatr Serv       Date:  2021-07-29       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.